There were 2,061 press releases posted in the last 24 hours and 353,442 in the last 365 days.
For Immediate Release: February 03, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced in a letter of enforcement discretion that it does not intend to object to …
For Immediate Release: January 31, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, Brian King, director of the Food and Drug Administration’s Center for Tobacco Products (CTP), …
For Immediate Release: January 31, 2023 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration As the oldest comprehensive consumer protection agency in the country, for more than a century the U.S. Food …
For Immediate Release: January 30, 2023 Today, the U.S. District Court for the Southern District of Florida entered a consent decree of permanent injunction against LGM Pharma LLC, an importer and distributor of active pharmaceutical ingredients (API), …
For Immediate Release: January 27, 2023 The U.S. Food and Drug Administration today announced it is proposing a change from time-based deferrals to assessing blood donor eligibility using gender-inclusive, individual risk-based questions to reduce the risk …
For Immediate Release: January 26, 2023 Statement From: Janet Woodcock, M.D. Principal Deputy Commissioner - Office of the Commissioner Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level …
For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a final guidance “Cannabis and Cannabis-Derived Compounds: Quality …
FDA News Release Company Must Stop Marketing Unauthorized Products or Risk Enforcement For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) for two menthol e-cigarette products currently …
For Immediate Release: January 24, 2023 Today, the U.S. Food and Drug Administration is announcing draft guidance for industry on action levels for lead in processed foods that are intended for babies and children under two years of age, to help reduce …
For Immediate Release: January 20, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an immediately-in-effect guidance on compounding certain ibuprofen products in …
For Immediate Release: January 13, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA released a fact sheet and constituent update to remind produce stakeholders of the …
For Immediate Release: January 10, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued the final guidance for the Foreign Supplier Verification Programs for Importers …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA posted an update that the agency is closely monitoring the emergence of the XBB.1.5 …
For Immediate Release: January 06, 2023 Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the second of a new category of medications …
For Immediate Release: February 01, 2023 Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment for anemia (decreased number of red blood cells) caused by chronic kidney disease for adults who have …
For Immediate Release: December 30, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced, through a Constituent Update and corresponding rule in the Federal Register, …
For Immediate Release: December 23, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA announced that the VQIP Application Portal would open on January 1, 2023 for …
For Immediate Release: December 22, 2022 Today, the U.S. Food and Drug Administration approved Sunlenca (lenacapavir), a new type of antiretroviral medication for adult patients living with human immunodeficiency virus type 1 (HIV-1), whose HIV infections …
For Immediate Release: December 20, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the agency published a piece for FDA Voices: “Office of Digital Transformation’s New Focus on …
FDA News Release Company prohibited from distributing drug products that violate the law For Immediate Release: December 19, 2022 Today, the U.S. District Court for the Western District of Oklahoma entered a consent decree against Qualgen LLC, an …
Don’t miss any breaking news!
Get the EIN Presswire App
Power your mobile with the latest breaking news by country, US state or industry.
